Method comprising the following steps: • providing a magnetic resonance fingerprint database, - wherein the magnetic resonance fingerprint database comprises database waveforms (CDS 1,..., CDS j) for a specific contrast agent in at least two different tissue types, a first tissue type and a second tissue type, wherein the contrast agent comprises gadoxetic acid or a salt of gadoxetic acid as contrast-enhancing active substance, the first tissue type being hepatocytes, - wherein the contrast agent has a different state in the first tissue type than in the second tissue type, the state being the molar T1 relaxivity and/or T2 relaxivity, • acquiring a magnetic resonance waveform ((x,y,z)(i)) for a volume element of an examination region by means of a magnetic resonance fingerprinting method using the contrast agent, wherein the volume element includes the first tissue type and the second tissue type, wherein the examination region is the liver or part of the liver of an examination object, • receiving database waveforms (CDS 1,..., CDS j) from the magnetic resonance fingerprint database, wherein each database waveform (CDS 1,..., CDS j) is matched to a T1 relaxation time and a T2 relaxation time in both tissue types as database values, • comparing the magnetic resonance waveform ((x,y,z)(i)) with database waveforms (CDS 1,..., CDS j), • identifying a database waveform (CDS k) having a defined correspondence with the magnetic resonance waveform ((x,y,z)(i)), • determining the associated database values for the T1 and T2 relaxation times in both tissue types in the volume element, based on the identified database waveform (CDS k), • calculating the concentration of the contrast agent in the first tissue type and the concentration of the contrast agent in the second tissue type for the volume element from the determined T1 and T2 relaxation times, • outputting the determined T1 and T2 relaxation times and/or the calculated concentrations of the contrast agent in the first tissue type and in the second tissue type for the volume element. • providing a magnetic resonance fingerprint database, - wherein the magnetic resonance fingerprint database comprises database waveforms (CDS 1,..., CDS j) for a specific contrast agent in at least two different tissue types, a first tissue type and a second tissue type, wherein the contrast agent comprises gadoxetic acid or a salt of gadoxetic acid as contrast-enhancing active substance, the first tissue type being hepatocytes, - wherein the contrast agent has a different state in the first tissue type than in the second tissue type, the state being the molar T1 relaxivity and/or T2 relaxivity, - wherein the magnetic resonance fingerprint database comprises database waveforms (CDS 1,..., CDS j) for a specific contrast agent in at least two different tissue types, a first tissue type and a second tissue type, wherein the contrast agent comprises gadoxetic acid or a salt of gadoxetic acid as contrast-enhancing active substance, the first tissue type being hepatocytes, - wherein the contrast agent has a different state in the first tissue type than in the second tissue type, the state being the molar T1 relaxivity and/or T2 relaxivity, • acquiring a magnetic resonance waveform ((x,y,z)(i)) for a volume element of an examination region by means of a magnetic resonance fingerprinting method using the contrast agent, wherein the volume element includes the first tissue type and the second tissue type, wherein the examination region is the liver or part of the liver of an examination object, • receiving database waveforms (CDS 1,..., CDS j) from the magnetic resonance fingerprint database, wherein each database waveform (CDS 1,..., CDS j) is matched to a T1 relaxation time and a T2 relaxation time in both tissue types as database values, • comparing the magnetic resonance waveform ((x,y,z)(i)) with database waveforms (CDS 1,..., CDS j), • identifying a database waveform (CDS k) having a defined correspondence with the magnetic resonance waveform ((x,y,z)(i)), • determining the associated database values for the T1 and T2 relaxation times in both tissue types in the volume element, based on the identified database waveform (CDS k), • calculating the concentration of the contrast agent in the first tissue type and the concentration of the contrast agent in the second tissue type for the volume element from the determined T1 and T2 relaxation times, • outputting the determined T1 and T2 relaxation times and/or the calculated concentrations of the contrast agent in the first tissue type and in the second tissue type for the volume element.